Physician profile
Anna Fieldman
NPI 1245332717
$1,250.13
in general payments reported to CMS, 2019-2025
19 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $78.13 · 2021: $143 · 2022: $153 · 2023: $141 · 2024: $90.34 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.31 | 2019-2025 | |
| Astellas Pharma US INC | $213.16 | 2023-2025 | Veozah |
| Pfizer INC. | $168.37 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $95.09 | 2022-2025 | |
| Millicent US INC | $90.10 | 2019-2025 | Femlyv, Femring, Intrarosa |
| Exeltis, USA INC. | $82.43 | 2019-2022 | |
| Avion Pharmaceuticals | $47.64 | 2019-2021 | |
| Coopersurgical, INC. | $40.40 | 2022-2023 | Paragard T 380a |
| Duchesnay USA Incorporated | $33.84 | 2019 | |
| Dysis Medical, INC. | $33.48 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.03 | 2024 | Vpriv |
| Vertical Pharmaceuticals, LLC | $23.82 | 2019 | |
| Organon LLC | $22.60 | 2022 | |
| Therapeuticsmd, INC. | $17.39 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $15.98 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.80 | 2021 | |
| Roche Diagnostics Corporation | $13.47 | 2019 | |
| Daiichi Sankyo INC. | $13.15 | 2023 | Injectafer |
| Mission Pharmacal Company | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Fieldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.